Barclays’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-10,000
Closed -$660K 5944
2015
Q3
$660K Sell
10,000
-5,000
-33% -$385K ﹤0.01% 3111
2015
Q2
$1.17M Hold
15,000
﹤0.01% 2736
2015
Q1
$1.06M Buy
+15,000
New +$962K ﹤0.01% 2912

Other funds holding ACHC

Barclays's ACHC Position: Q2 2026 in Review

Barclays increased its Acadia Healthcare (ACHC) stake by 548% in Q2 2026, buying an estimated $17.8M and bringing the position to 821,340 shares worth $24.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1031.

Barclays first reported a position in ACHC in Q2 2013 and has held it in 53 quarters since. The position peaked at $46.4M in Q2 2024. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Barclays held 821,340 shares of Acadia Healthcare worth $24.3M as of Q2 2026.
  • Barclays bought 694,659 Acadia Healthcare shares in Q2 2026, an estimated $17.8M.
  • Acadia Healthcare made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1031 holding.
  • Barclays first reported a position in Acadia Healthcare in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Acadia Healthcare position peaked at $46.4M in Q2 2024.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.